Видео ютуба по тегу Natalizumab

What You Need to Know About Natalizumab (Tysabri®)
What You Need to Know About Natalizumab (Tysabri®)
B1 4.5 Ремиссия РС - Ведение пациентов с РС на натализумабе
B1 4.5 Ремиссия РС - Ведение пациентов с РС на натализумабе
Bench to Bedside: Multiple Sclerosis and Tysabri, Part 1 - Ted Yednock
Bench to Bedside: Multiple Sclerosis and Tysabri, Part 1 - Ted Yednock
How Tysabri (natalizumab) works in Multiple Sclerosis
How Tysabri (natalizumab) works in Multiple Sclerosis
Additional Insights from Natalizumab Treatment in MS
Additional Insights from Natalizumab Treatment in MS
Safely switching from natalizumab to ocrelizumab in patients with MS at risk of PML
Safely switching from natalizumab to ocrelizumab in patients with MS at risk of PML
Answering Viewers Questions: Tysabri (Natalizumab) and JC Virus
Answering Viewers Questions: Tysabri (Natalizumab) and JC Virus
Benefits of SC natalizumab in MS
Benefits of SC natalizumab in MS
Risk Analysis of Natalizumab in Progressive Multifocal Leukoencephalopathy
Risk Analysis of Natalizumab in Progressive Multifocal Leukoencephalopathy
How Tysabri (natalizumab) Works in Relapsing Multiple Sclerosis
How Tysabri (natalizumab) Works in Relapsing Multiple Sclerosis
Natalizumab concentrations during pregnancy in MS patients
Natalizumab concentrations during pregnancy in MS patients
NEXT-MS trial: natalizumab personalized extended interval dosing
NEXT-MS trial: natalizumab personalized extended interval dosing
Dr Paul Molyneux - Managing PML risk in patients treated with Natalizumab.
Dr Paul Molyneux - Managing PML risk in patients treated with Natalizumab.
Updates on natalizumab and anti-CD20 antibodies for MS
Updates on natalizumab and anti-CD20 antibodies for MS
Natalizumab: a strategy for immunization to avoid delays of treatment onset in highly active MS
Natalizumab: a strategy for immunization to avoid delays of treatment onset in highly active MS
Extending Natalizumab's Use Without Increasing Risk to Patients
Extending Natalizumab's Use Without Increasing Risk to Patients
Review of Natalizumab for MS
Review of Natalizumab for MS
Impact of natalizumab on chronic active MS lesions
Impact of natalizumab on chronic active MS lesions
Biologics and Biosimilars in Multiple Sclerosis
Biologics and Biosimilars in Multiple Sclerosis